摘要
从出生到死亡,神经元和神经胶质细胞动态相随并有着十分紧密的形态和功能的关系。三种中枢神经内的类型传统上分为:星形胶质细胞、少突胶质细胞和小胶质细胞。许多类型/亚型(包括 NGR2+细胞),在神经元上具有各种各样的生理和病理影响,已使用形态学和免疫细胞化学标准进行描述。胶质,胶质神经元和神经胶质细胞信号以及gliotransmission 是支持大脑功能必不可少的现象。形态功能的变化由所有胶质细胞类型的可塑性平行于可塑性神经元的变化导致,这可以优化神经回路功能。此外,神经胶质细胞拥有适应活性状态的能力,一般来说,它能改善和恢复损伤神经的功能。当试图解释中枢神经系统中的任何生理或病理过程时,所有这些特点使胶质细胞元素至关重要。因为它们参与了神经保护/修复和神经退行性疾病。目前存在着不同的,深刻的,区域的和地方的神经胶质细胞,它们在所有合过程中变化(生理性和病理性老化;神经退行性疾病,包括阿尔兹海默病 –AD-),但目前,这样修改的确切含义(不同神经胶质的修改 类型,时间和位置)并不是很清楚。在本文中,为了解他们在发病机制,以及诊断和治疗中(预防或姑息)的可能作用,我们考虑了不同的神经胶质细胞和他们的反应。分化和/或致病性以及神经保护/神经修复的星形胶质细胞和小胶质细胞反应也被特别强调了。
关键词: 阿尔茨海默病;星形胶质细胞增生;胶质细胞的可塑性;神经胶质退行型/神经保护;胶质细胞增生;神经胶质细胞;胶质细胞反应。
Current Alzheimer Research
Title:Brain local and regional neuroglial alterations in Alzheimer´s Disease: cell types, responses and implications.
Volume: 13 Issue: 4
Author(s): Adolfo Toledano, Maria-Isabel Alvarez, Adolfo Toledano-Diaz, Jose-Joaquin Merino, Jose Julio Rodriguez
Affiliation:
关键词: 阿尔茨海默病;星形胶质细胞增生;胶质细胞的可塑性;神经胶质退行型/神经保护;胶质细胞增生;神经胶质细胞;胶质细胞反应。
摘要: From birth to death, neurons are dynamically accompanied by neuroglial cells in a very close morphological and functional relationship. Three families have been classically considered within the CNS: astroglia, oligodendroglia and microglia. Many types/subtypes (including NGR2+ cells), with a wide variety of physiological and pathological effects on neurons, have been described using morphological and immunocytochemical criteria. Glio-glial, glio-neuronal and neuro-glial cell signaling and gliotransmission are phenomena that are essential to support brain functions. Morphofunctional changes resulting from the plasticity of all the glial cell types parallel the plastic neuronal changes that optimize the functionality of neuronal circuits. Moreover, neuroglia possesses the ability to adopt a reactive status (gliosis) in which, generally, new functions arise to improve and restore if needed the neural functionality. All these features make neuroglial cells elements of paramount importance when attempting to explain any physiological or pathological processes in the CNS, because they are involved in both, neuroprotection/neurorepair and neurodegeneration. There exist diverse and profound, regional and local, neuroglial changes in all involutive processes (physiological and pathological aging; neurodegenerative disorders, including Alzheimer ´s disease –AD-), but today, the exact meaning of such modifications (the modifications of the different neuroglial types, in time and place), is not well understood. In this review we consider the different neuroglial cells and their responses in order to understand the possible role they fulfill in pathogenesis, diagnosis and treatment (preventive or palliative) of AD. The existence of differentiated and/or concurrent pathogenic and neuro-protective/neuro-restorative astroglial and microglial responses is highlighted.
Export Options
About this article
Cite this article as:
Adolfo Toledano, Maria-Isabel Alvarez, Adolfo Toledano-Diaz, Jose-Joaquin Merino, Jose Julio Rodriguez , Brain local and regional neuroglial alterations in Alzheimer´s Disease: cell types, responses and implications., Current Alzheimer Research 2016; 13 (4) . https://dx.doi.org/10.2174/1567205013666151116141217
DOI https://dx.doi.org/10.2174/1567205013666151116141217 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pathological Gambling in Parkinson’s Disease: An Update on Medical Management
Current Psychopharmacology Amyloid Formation by Transthyretin: From Protein Stability to Protein Aggregation
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents ESVS Guidelines: Section B - Diagnosis and Investigation of Patients with Carotid Stenosis
Current Vascular Pharmacology How Should We Deal with Missing Data in Clinical Trials Involving Alzheimers Disease Patients?
Current Alzheimer Research Pharmacological Intervention at Ionotropic Glutamate Receptor Complexes
Current Pharmaceutical Design Multifunctional Lipoic Acid Conjugates
Current Medicinal Chemistry COPD Evaluation: Beyond the Airway Obstruction, a Follow Up
Current Respiratory Medicine Reviews Comparison of Machine Learning Techniques Based Brain Source Localization Using EEG Signals
Current Medical Imaging Erythrocyte Associated Amyloid-β as Potential Biomarker to Diagnose Dementia
Current Alzheimer Research Metabolic Control of Glia-Mediated Neuroinflammation
Current Alzheimer Research Editorial (Thematic Issue: Current Update on Association Between Alzheimer’s Disease and Type 2 Diabetes: Volume I)
CNS & Neurological Disorders - Drug Targets Inflammation, Oxidative Stress and Metabolic Syndrome: Dietary Modulation
Current Vascular Pharmacology Perispinal Etanercept for Treatment of Alzheimers Disease
Current Alzheimer Research Effects of Yokukansan, a Japanese Kampo Medicine for Symptoms Associated Autism Spectrum Disorder
CNS & Neurological Disorders - Drug Targets Neuroimaging Features of Acquired Metabolic and Toxic Encephalopathies
Current Medical Imaging EHT0202 in Alzheimers Disease: A 3-Month, Randomized, Placebo- Controlled, Double-Blind Study
Current Alzheimer Research Glutamate in CNS Neurodegeneration and Cognition and its Regulation by GCPII Inhibition
Current Medicinal Chemistry Fluorescent Imaging of Amyloid-β Deposits in Brain: An Overview of Probe Development and a Highlight of the Applications for In Vivo Imaging
Current Medicinal Chemistry Treatments for Hypertension in Type 2 Diabetes-Non-pharmacological and Pharmacological Measurements<sup>#</sup>
Current Hypertension Reviews Editorial [Hot topic: Antiretroviral, Anti-Inflammatory and Dopaminergic Substances in the Treatment of HIV-Infection (Guest Editor: Gabriele Arendt)]
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry